CapsoVision (CV) Change in Accured Expenses (2024 - 2025)

CapsoVision (CV) reported Change in Accured Expenses of -$92000.0 for Q4 2025, up 86.57% on a YoY basis from -$49311.4 in Q4 2024, and down 107.66% sequentially from $1.2 million in Q3 2025.

CapsoVision (CV) Change in Accured Expenses (2024 - 2025) Analysis & Trends

CapsoVision (CV) has 2 years of Change in Accured Expenses data on file, last reported at -$92000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses rose 86.57% year-over-year to -$92000.0; the trailing twelve-month figure through Dec 2025 stood at -$404000.0 (changed N/A YoY), and the FY2025 full-year result was $2.1 million, up 1143.14% from the prior year.
  • Change in Accured Expenses declined to -$92000.0 in Q4 2025, from $1.2 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.2 million in Q3 2025 to a low of -$828000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -654.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 123.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -512.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -347.10 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 145.10 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 21.07 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -250.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 CapsoVision 162.07 Mn 151.95 Mn 1.95 Mn -92,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -92,000.00
Dec 31, 2025 -92,000.00
Sep 30, 2025 1.20 Mn
Sep 30, 2025 1.20 Mn
Dec 31, 2024 -685,000.00
Dec 31, 2024 -685,000.00
Sep 30, 2024 -828,000.00
Sep 30, 2024 -828,000.00